Exact Sciences diskutieren
Exact Sciences
WKN: 590273 / Symbol: EXAS / Name: EXACT Sci / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
41,90 €
-0,47 %
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Benchmark Co. from $54.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $85.00 to $110.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $83.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Piper Sandler from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $100.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $95.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) is now covered by analysts at Guggenheim. They set a "buy" rating and a $90.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $91.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its "buy" rating re-affirmed by analysts at Citigroup Inc.. They now have a $100.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Citigroup Inc. from $100.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at BTIG Research from $85.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Neueste Beiträge
StockNews_com in Arch Capital Group diskutieren